Unexpected Clinical Drug-Drug Interaction of Fexinidazole on Midazolam Pharmacokinetics: Insights into Underlying Mechanisms from Clinical Phase I Study Results and Supporting In Vivo/Vitro Evidence
Authors
Sean M. Hays (ORCID: https://orcid.org/0000-0001-7233-8244)
Unexpected Clinical Drug-Drug Interaction of Fexinidazole on Midazolam Pharmacokinetics: Insights into Underlying Mechanisms from Clinical Phase I Study Results and Supporting In Vivo/Vitro Evidence
Sean M. Hays, Valérie Wauthier, Priscilla Brun, Olivier Nicolas et al.
Journal
Clinical Drug Investigation
Topics
Pharmacogenetics and Drug Metabolism
article
Unexpected Clinical Drug-Drug Interaction of Fexinidazole on Midazolam Pharmacokinetics: Insights into Underlying Mechanisms from Clinical Phase I Study Results and Supporting In Vivo/Vitro Evidence
Sean M. Hays, Valérie Wauthier, Priscilla Brun, Olivier Nicolas, Eric Sultan, Franck Da Silva, Matthieu Gassiot
article en
Abstract
No abstract available for this paper.
Publication Tag
Clinical Drug InvestigationVol. 46(2)
Institutions
Sanofi (France) (FR), Structure Fédérative de Recherche en Biologie et Santé de Rennes (FR), SGS (Belgium) (BE)